Central Hospital in Finland Automates Symptom Tracking of Coronavirus-Infected Patients' with Help of an App

Buddy HealthcareThis November Central Ostrobothnia Central Hospital in Finland has started symptom tracking and remote monitoring of corona virus-infected patients with the Buddy Healthcare mobile application and clinical monitoring platform. The patient management platform digitizes and automates the symptom tracking process and enables secure two-way communication between patients and healthcare professionals.

The well-being of coronavirus-infected patients can change quickly, and therefore daily monitoring of symptoms is essential. After a patient has been diagnosed with a coronavirus infection, the Central Ostrobothnia Central Hospital's infectious disease unit provides the patient with instructions on downloading the BuddyCare mobile application to a smartphone or a tablet.

Coronavirus-infected patients are being asked to submit daily symptom tracking questionnaires through the mobile app over a two week period. If the healthcare professional's set thresholds are exceeded, the infectious disease unit receives an alert on their dashboard. In addition to the symptom tracking feature, patients receive information related to the coronavirus infection, and they can send questions to care personnel through secure real-time messaging. The mobile application and remote patient monitoring dashboard bring peace of mind to the patients as they know that their well-being and symptoms are being monitored every day.

Digitized symptom tracking through the mobile application helps the Central Ostrobothnia Central Hospital in automating the collection and monitoring of symptom tracking questionnaires. Previously, the hospital was contacting infected patients daily by telephone and the data was being entered manually into hospital files. The use of the BuddyCare platform decreases the need to manually track symptoms through telephone calls.

The BuddyCare patient management platform has previously been used to educate, support and monitor surgery patients before and after procedures, recently expanding to other traditional medical specialties. During spring 2020, Buddy Healthcare published its COVID-19 symptom tracking and remote patient monitoring features to support hospitals during the coronavirus pandemic.

Read more about Buddy Healthcare's solution to track and monitor coronavirus-infected patients.

About Buddy Healthcare

Buddy Healthcare is a European based digital health company specialising in automating hospitals’ care co-ordination and patient communication processes. The company was founded in 2016 and the care co-ordination platform was co-created in collaboration with university hospitals in Finland.

The company initially started producing intelligent and automated surgical care pathways, but it has rapidly expanded to other medical specialities. With the help of the Platform hospitals can guide, monitor and manage patients’ care pathways. The Plaform collects automatically forms and questionnaires such as pre-assessment forms, patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs).

The BuddyCare software has the CE mark and is GDPR and HIPAA compliant.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...